Provigil better than placebo for bipolar depression Carlat Reports

Provigil better than placebo for bipolar depression

The Carlat Psychiatry Report, Volume 5, Number 9, September 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n9/

From The Carlat Psychiatry Report, September 2007, Complex Psychopharmacology

Issue Links: Learning Objectives | Editorial Information

Ronald Pies, MD

In a study only partially funded by the manufacturer of Provigil (modafinil), 85 patients with bipolar depression, already taking mood stabilizers, were randomly assigned to augmentation with Provigil (N=41) or placebo (N=44).

You can't view details of this content, please login or buy subscription here

Ronald Pies, MD

Professor of Psychiatry, SUNY Upstate Medical University, Syracuse Clinical Professor of Psychiatry, Tufts Univeristy School of Medicine, Boston

Dr. Pies has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.